ABSTRACT We investigated effects of eggshell temperature (EST) of 35.6, 36.7, 37.8, or 38.9 • C applied from d of incubation (E) 15, E17, or E19 onward on chicken embryo physiology. A total of 2,850 first-grade eggs of a 43-week-old Ross 308 broiler breeder flock were incubated at an EST of 37.8
INTRODUCTION
Temperature is one of the most important factors during incubation and affects embryonic growth and development (Ricklefs, 1987; French, 1994; Christensen et al., 1999) . Embryo temperature during incubation is proven to better reflect embryonic metabolism than incubator temperature (Lourens et al., 2005; Meijerhof, 2009 ). As a reflection of embryo temperature, eggshell temperature (EST) can be used as a noninvasive method (Lourens et al., 2005) .
Studies have shown that an EST ≥ 38.9
• C from d of incubation (E) 14 onward or even during only the hatching phase (E19 till hatch) has negative effects on embryonic development (Leksrisompong et al., 2007; Maatjens et al., 2014a; Maatjens et al., 2016a ). An EST of 35.6 or 36.7 • C applied during the last wk of incubation or an EST of 36.7
• C during only the hatching phase has been shown to have beneficial effects on embryonic development and chick quality (Maatjens et al., 2014a (Maatjens et al., , 2016a .
Towards the end of incubation, embryonic energy and oxygen requirements increase due to the high metabolic rate. However, between E15 and E19, exchange of oxygen (O 2 ) and carbon dioxide (CO 2 ) is restricted due to limited shell and shell membrane porosity, which results in a plateau phase in heat production (Lourens et al., 2007) until internal pipping (IP), when supplementary O 2 from lung respiration in the air cell becomes available.
When O 2 becomes limited, yolk lipids cannot be used efficiently for energy production and the embryo will depend more on carbohydrate and protein metabolism, as more O 2 is needed for lipid oxidation than for carbohydrate and protein oxidation (Moran, 2007; de Oliveira et al., 2008) .
The last wk of incubation and the hatching phase are characterized by physiological and metabolic processes that are essential for embryonic survival and hatching (Christensen et al., 1999) . One of these processes involves the synthesis and degradation of glycogen stores (Freeman, 1969; Garcia et al., 1986; Christensen et al., 2001) . Effects of EST treatments on hepatic glycogen were described by Molenaar et al. (2011) who found a lower total hepatic glycogen at hatch when an EST of 38.9
• C was applied from E7 onward compared to an EST of 37.8
• C. Maatjens et al. (2014b) showed that when an EST of 38.9
• C was applied during only the hatching phase, hepatic glycogen concentration was lower at the moment of IP and hatch compared to an EST of 36.7 or 37.8
• C. Effects of EST during incubation on plasma metabolites, such as plasma glucose, lactate, and uric acid, are not thoroughly investigated. Molenaar et al. (2013) found a higher plasma lactate at E17.8 and a higher plasma uric acid concentration at E21.6, when an EST of 38.9
• C was applied from E10.5 onward compared to an EST of 37.8
• C. Maatjens et al. (2014b) found a higher plasma lactate only at 12 h after hatch when an EST of 38.9
• C was applied during the hatching phase compared to an EST of 37.8 or 36.7
• C (Maatjens et al., 2014b) . Therefore, it can be suggested that an EST lower than 37.8
• C applied during the hatching phase is beneficial for embryo physiology.
However, it can be questioned whether a lower EST than 36.7
• C might be even more beneficial for embryo physiology, and, additionally, it is largely unknown from which moment onward these lower EST will affect embryo development, including embryo physiology. Therefore, we aimed to investigate effects of an EST of 35.6, 36.7, 37.8, and 38.9 • C starting from E15, E17, or E19 onward on embryo physiology.
MATERIALS AND METHODS

Experimental Design
The experiment was set up as a 3 × 3 factorial design and an "added" control.
Eggs were incubated at an EST of 37.8
• C until E15. From E15, E17, or E19 onward, EST was changed to 35.6, 36.7, or 38.9 , or maintained at 37.8
• C. Table 1 shows an overview of the different treatment groups, i.e., changes in EST at E15, E17, or E19. The experimental protocol was approved by the Institutional Animal Care and Use Committee of Wageningen University, the Netherlands.
Egg Storage and Incubation up to E15
Before incubation, eggs were stored for 5 d at a storage temperature of 20
• C at a commercial hatchery (Lagerwey BV, Lunteren, the Netherlands). In total, EST; 35.6, 36.7, 37.8, 38.9 • C) applied from 3 starting points (E; E15, E17, or E19) through hatch. 2,850 first-grade eggs of a 43-week-old Ross 308 broiler breeder flock were selected on an egg weight between 62 and 65 g. For the first 15 d of incubation, the selected eggs were placed in one incubator (HatchTech BV, Veenendaal, the Netherlands) with a capacity of 4,800 eggs. The rest of the incubator was filled with hatching eggs that were not part of the experiment to ensure uniform airflow across eggs. Eggshell temperatures were automatically maintained at 37.8
• C until E15. EST was controlled and monitored by 4 eggshell temperature sensors (NTC Thermistors: type DC 95; Thermometrics, Somerset, UK), which were placed halfway the blunted and pointed end of 4 individual fertile eggs. Incubator temperature was adjusted based on the average temperature of the 4 EST sensors. RH was maintained between 50 and 55% and CO 2 concentration did not exceed 0.35%. Eggs were placed on setter trays and turned hourly by an angle of 45
• .
Incubation from E15 Until Hatch
At E14 (332 h), eggs were candled to identify infertile eggs or eggs containing non-viable embryos. All eggs containing viable embryos were transported to the experimental facility of Wageningen University (Wageningen, the Netherlands) for 30 min in a climate-controlled car.
At E15 (336 h), after arrival at the experimental facility, 3 times 240 eggs were assigned to one out of 4 climate respiration chambers (Heetkamp et al., 2015) in which EST was maintained at 35.6
• C (treatment 1), 36.7
• C (treatment 2), or 38.9
• C (treatment 4). The remaining 2,130 eggs were placed in the control climate respiration chamber in which EST was maintained at 37.8
• C (treatment 3) ( Table 1) . At E17 (384 h), 3 times 210 eggs were moved from the control climate respiration chamber to one of the 3 climate respiration chambers in which EST was maintained at 35.6
• C (treatment 5), 36.7
• C (treatment 6), or 38.9
• C (treatment 7). Finally, at E19 (432 h), 3 times 180 eggs were moved from the control climate respiration chamber to one of the 3 climate respiration chambers in which EST was maintained at 35.6
• C (treatment 8), 36.7
• C (treatment 9), or 38.9
• C (treatment 10) ( Table 1 ).
All eggs were placed in individual hatching baskets (120 × 135 mm) and eggs and chicks were continuously exposed to light. From E15 (336 h) until hatch, EST was monitored by the median of 5 individual eggshell sensors per climate respiration chamber as described before. At E19 (453 h), the temperature of each climate respiration chamber was fixed at its current setting and EST was allowed to increase during the hatching process. In each climate respiration chamber, RH was maintained between 50 and 55% and CO 2 concentration did not exceed 0.35%.
From E19 (453 h) of incubation onward, the moment of IP, which was determined by candling all eggs individually, external pipping (EP), and hatch were monitored every 6 hours.
Eggs were allowed to hatch and chicks remained in individual hatching baskets, without feed and water under continuous light.
Sampling from E15 Until Hatch
At E15 (336 h), before dividing the eggs over the treatments, 30 eggs were randomly chosen to be used for determination of embryonic blood parameters and hepatic glycogen determination.
At the same moment, at E15, 30 eggs per treatment were randomly assigned to be used for determination of embryonic blood parameters and hepatic glycogen at E17, E19, IP, and EP. All other eggs were allowed to hatch and at hatch 30 randomly chosen chicks per treatment, divided over the hatch window, were sampled for blood parameters and hepatic glycogen.
All chicks that were not used for sampling were used for a first wk grow-out trial, described in Maatjens et al. (2016b) .
Blood Parameter Measurements and Hepatic Glycogen Determination
At E15 (336 h), blood was extracted from the allantoic vein of the chorioallantoic membrane using a one-mL syringe and 30-gauge needle and collected in heparinized tubes.
At E17 (384 h), E19 (432 h), IP, EP, and hatch, blood was extracted from the jugular vein of the embryos or chicks using a one-mL syringe and 30-gauge needle and collected in heparinized tubes.
Blood was centrifuged (2,900 x g) at 4
• C for 15 minutes. Plasma was decanted and stored at −20.0
• C until further analysis.
Plasma glucose, lactate, and uric acid were determined with commercially available enzymatic kits (plasma glucose: Cobas, Roche Diagnostics, the Netherlands; plasma lactate and uric acid: DiaSys Diagnostic Systems International, Holzheim, Germany).
After blood collection, embryos or chicks were decapitated and the liver was dissected. After determination of liver weight, livers were frozen in liquid nitrogen and stored at −80.0
• C until further analysis. Procedures to determine hepatic glycogen were carried out on ice. Approximately 300 mg of liver was homogenized after the addition of the same amount of μL 7% HClO 4 as mg tissue. The suspension was centrifuged (2,900 x g) at 4
• C for 15 minutes. The supernatant was decanted, cleaned with one mL of petroleum ether, and frozen at −20.0
• C until further analysis. Hepatic glycogen was determined by the iodine binding assay described by Dreiling et al. (1987) and hepatic bovine glycogen (Type IX, SigmaAldrich Chemie GmbH, Steinheim, Germany) was used as a standard.
For relative weights of the heart, liver, spleen, stomach, and intestines at E15, E17, E19, IP, EP, and hatch see Maatjens et al. (2016a) .
Statistical Analysis
Separate analyses were performed for the data collected at E17, E19, IP, EP, and hatch. Based on the design, the experiment consists of 10 treatment groups, i.e., different EST and changes in EST at E15, E17, or E19 (Table 1) .
At E17, there were 4 treatments (eggs moved from 37.8
• C to another EST, plus a control treatment of eggs constantly at 37.8
• C) in a completely randomised design that was analyzed by one-way ANOVA. The F-test was used to test for overall differences among treatments, followed by pairwise comparisons by Fisher's LSD method.
At E19, there were 7 treatments, consisting of combinations of EST in 2 time trajectories (E15 to E17, E17 to E19). By introducing factors for EST (35.6, 36.7, 38.9 • C) and for starting d of treatment (eggs moved after E15 or E17), the design consists of a 3 × 2 factorial scheme (eggs moved from 37.8
• C to another EST after E15 or E17) and an "added" control (eggs constantly at 37.8
• C). All data were analyzed with a single model in a single analysis. F-tests were performed for interaction and main effects of EST and starting d of treatment corresponding to the 3 × 2 factorial scheme. Depending upon the significance of the interaction, pairwise comparisons with Fisher's LSD method were made among the 6 means of combinations of EST and starting d of treatment (P-value interaction ≤ 0.05), or among the separate 3 means for EST and 2 means for starting d of treatment (P-value interaction > 0.05). Similarly, depending upon the significance of the interaction, the control treatment was compared with the 6 means of combinations of 3 EST and 2 starting d of treatment, or with the separate 3 means for EST and 2 means for starting time of the treatment.
At IP, EP, and hatch, there were 10 treatments, consisting of EST in 3 time trajectories (E15 to E17, E17 to E19, >E19). Introducing factors for EST and starting d of treatment (eggs moved after E15, E17, or E19), the design consists of a 3 × 3 factorial scheme (eggs moved from 37.8
• C to another EST after E15, E17, or E19) and an "added" control (eggs constantly at 37.8 • C). Again, F-tests were performed and, depending upon the significance of interaction, appropriate pairwise comparisons by Fisher's LSD method were made, similar to the analysis at E19.
Model assumptions, i.e., normality and equal variance of the error terms in the linear models, were checked by inspection of residual plots.
For the analyses of uric acid concentration, a log transformation was applied at E17, E19, IP, and hatch to obtain normally distributed data.
For the analyses of total glycogen and glycogen concentration at E17, E19, and IP, normality of the residuals could not be attained. Preliminary analyses indicated that a Poisson distribution fit the data better. Therefore, total glycogen and glycogen concentration were analyzed using PROC GLIMMIX, using a Poisson distribution with a log link to model the linear regression analysis. Models included the same variables as described above. Results are displayed as the inverted natural logarithm least squares means and the corresponding confidence interval (CI).
All analyses were performed with SAS (Version 9.3, SAS Institute 2010).
RESULTS
Day 15 of Incubation (Baseline Values)
At E15 (336 h), baseline values were assessed for total hepatic glycogen, hepatic glycogen concentration, plasma glucose, uric acid, and lactate (mean ± SEM). Total hepatic glycogen and hepatic glycogen concentration were 2.24 ± 0.34 mg and 7.23 ± 1.05 mg/g, respectively. Values for plasma metabolites were 115.65 ± 4.63 mg/mL for glucose, 3.85 ± 0.35 mg/mL for uric acid, and 1.18 ± 0.09 mmol/L for lactate.
Plasma Glucose
No interactions between EST and starting d of treatment were found for plasma glucose.
At E17, glucose was higher at an EST of 35.6 and 38.9
• C compared to 36.7, with 37.8
• C intermediate (P = 0.02; Table 2 ). At IP, glucose was higher at an EST of 36.7
• C compared to 35.6 and 37.8, with 38.9
• C intermediate (P = 0.008). At EP, glucose was higher at an EST of 36.7 and 37.8
• C compared to 35.6 and 38.9
• C (P = 0.02). At E19 and hatch, no effect of EST or starting d of treatment was found.
Plasma Uric Acid
No interactions between EST and starting d of treatment were found for plasma uric acid.
At E17, uric acid was higher at an EST of 35.6 and 38.9
• C ; 35.6, 36.7, 37.8, or 38.9 • C) applied from 3 starting points (E15, E17, or E19) through hatch on plasma glucose concentration (mg/100 mL) at E17, E19, internal pipping (IP), external pipping (EP), and hatch (H) (n = 30 per treatment). Table 3 ). At E19, uric acid was higher at an EST of 35.6
• C compared to 36.7 and 37.8
• C. Uric acid at an EST of 38.9
• C was comparable to 35.6 and 36.7, but higher compared to 37.8
• C (P = 0.03). At EP, uric acid was higher at an EST of 35.6 compared to 38.9
• C, with 36.7 and 37.8
• C intermediate (P = 0.008). At hatch, uric acid was higher at an EST of 35.6
• C compared to all other EST treatments (P < 0.001).
At IP, no effect of EST or starting d of treatment was found.
Plasma Lactate
At E17, IP, EP, and hatch, no effect of EST or starting d of treatment was found.
At E19, an interaction between EST and starting d of treatment was found for lactate (P = 0.01; Table 4 ). Lactate was similar at an EST of 35.6 and 36.7
• C for all starting d of treatment. At an EST of 38.9
• C, lactate was higher when treatment started at E17 compared to E15. Lactate at an EST of 37.8
• C was similar to the 38.9
• C-E17 treatment, but higher compared to all other treatments.
Hepatic Glycogen
No interactions between EST and starting d of treatment were found for total hepatic glycogen and hepatic glycogen concentration.
At E17 and E19, no effect of EST or starting d of treatment was found on total hepatic glycogen. At IP, total hepatic glycogen amount differed among all EST treatments with the highest amount at an EST of 35.6
• C, followed by 36.7, 37.8, and 38.9
• C (P < 0.001; Table 5 ). At EP, total hepatic glycogen amount was Table 3 . Effects of 4 eggshell temperatures (EST; 35.6, 36.7, 37.8, or 38.9 • C) applied from 3 starting points (E15, E17, or E19) through hatch on plasma uric acid concentration (mg/100 mL) at E17, E19, internal pipping (IP), external pipping (EP), and hatch (H) (n = 30 per treatment). • C-E15: 1.61 c , 38.9
• C-E17: 2.11 a,b . a-c Least squares means lacking a common superscript within a column and factor differ (P ≤ 0.05).
higher at an EST of 35.6 and 36.7
• C compared to 37.8 and 38.9
• C (P = 0.05). At hatch, total hepatic glycogen amount was higher at an EST of 35.6
• C compared to all other EST treatments (P < 0.001), which did not differ from each other.
At E17, no effect of EST was found on hepatic glycogen concentration.
At E19, the hepatic glycogen concentration was higher at an EST of 36.7
• C, compared to 35.6 and 38.9 with 37.8
• C intermediate (P = 0.05; Table 6 ). At IP, hepatic glycogen concentration was different among all EST treatments with the highest amount at an EST of 35.6
• C (P < 0.001). At EP, hepatic glycogen concentrations were both higher at an EST of 35.6 and 36.7
• C (P = 0.05). At hatch, hepatic glycogen concentration was higher at an EST of 35.6
An effect of starting d of treatment was found at hatch, at which hepatic glycogen concentration was higher when treatment was applied from E19 compared to E15 (P = 0.05), where the control treatment and treatment applied from E17 were intermediate.
DISCUSSION
The aim of the experiment was to investigate whether an EST of 35.6, 36.7, 37.8, or 38.9 • C applied from different d (E15, E17, or E19) of incubation onward affected embryonic physiology.
During the last wk of incubation, the different developmental phases might affect the sensitivity of physiology parameters. Therefore, E17 and 19 might physiologically not be the same moments in development for the different treatments. In addition, the variation in incubation duration due to applied EST treatments (Maatjens et al., 2016a ) might affect embryo physiology as well. Maatjens et al. (2016a) showed that an EST of 35.6 and 36.7
• C from E15 onward appears to be beneficial for embryo development, expressed by a higher yolkfree body mass (YFBM) and higher relative organ weights at hatch. In the current study, EST affected blood plasma glucose, uric acid, and lactate concentration. Total hepatic glycogen and hepatic glycogen concentration were affected by EST as well, indicating that besides embryonic organ growth, embryo physiology is affected by EST during the last wk of incubation. ; 35.6, 36.7, 37.8, or 38.9 • C) applied from 3 starting points (E15, E17, or E19) through hatch on total hepatic glycogen (mg) at E17, E19, internal pipping (IP), external pipping (EP), and hatch (H) (n = 30 per treatment). ; 35.6, 36.7, 37.8, or 38.9 • C) applied from 3 starting points (E15, E17, or E19) through hatch on hepatic glycogen concentration (mg/g) at E17, E19, internal pipping (IP), external pipping (EP), and hatch (H) (n = 30 per treatment). An increase in EST from 37.8 to 38.9
• C from E15 onward normally results in an immediate increase in metabolic rate, which in turn affects embryonic heat production (Lourens et al., 2006) and embryonic growth and development (Romanoff, 1936; Ricklefs, 1987; Christensen et al., 1999) . However, there is a limit to the positive relationship between EST and metabolic rate, because metabolic rate drives the request for O 2 . The exchange of O 2 and CO 2 between E15 and E19 becomes limited due to limited shell and shell membrane porosity, which results in a plateau phase in heat production (Romijn and Lokhorst, 1956; Lourens et al., 2007) . Therefore, it is assumed that at a high EST, a dis-balance between metabolic rate and O 2 availability for the embryo, results in lower energy utilization and the conversion of egg nutrient sources into body development. This dis-balance is suggested to occur especially during the second part of the incubation process.
The suggested higher metabolic rate at an EST of 38.9
• C compared to all other EST was accompanied by a decrease in hepatic glycogen amount from E19 to IP and lower glycogen amount at IP, which indicates that glucogenic energy was needed to support embryonic metabolic rate and that glucose was not used for hepatic glycogen synthesis. Earlier research indicated that at a high EST of 38.9
• C, glucose oxidation was increased (Molenaar et al., 2013) and glycogen synthesis was depressed (Maatjens et al., 2014b) , compared to an EST of 37.8
• C, which necessitates the use of blood glucose for immediate energy instead of glycogen synthesis. This may be explained because embryos reach the O 2 limiting stage towards the end of incubation and fat oxidation as an energy source requires more O 2 than glucose oxidation.
At EP, when O 2 availability increases greatly, an EST of 38.9
• C resulted in a lower plasma glucose concentration compared to 36.7 and 37.8
• C. In combination with the higher glycogen amount and glycogen concentration at EP compared to IP, this suggests that plasma glucose between IP and EP at an EST of 38.9
• C might be mainly used for building up hepatic glycogen reserves for the energy demanding hatching phase. However, at an EST of 38.9
• C, hepatic glycogen levels remain considerably lower at IP, EP, and hatch as compared to an EST of 35.6 and 36.7
• C. Opposite to the effect of a higher EST of 38.9
• C, we also investigated effects of lower EST of 35.6 and 36.7
• C applied from E15 onward on embryo physiology. In general, a decrease in EST from 37.8 to 35.6
• C from E15 onward likely decelerated embryonic metabolic rate because chick embryos act as poilkilotherm and have limited abilities to regulate their own body temperature (Romijn and Lokhorst, 1955) , meaning that lower ambient temperature results in lower metabolic rate. However, embryos become more responsive to external stimuli, such as temperature (Lourens et al., 2006) between E14 and E18 (Nichelmann and Tzschentke, 2003) . The decrease in EST might have caused a decreased blood flow in the chorioallantoic membrane (CAM), which indicates the proximate non-adaptive reaction (Tzschentke, 2007) .
At a lower metabolic rate, O 2 availability is similar resulting in a sustained sufficient O 2 supply by the CAM relative to the embryo's metabolic rate, and therefore yolk fat can continue to be used as a main energy source (Moran, 2007) . During that process, triacylglycerol is mobilized from yolk fat to free fatty acids. Fatty acids release Acetyl-CoA, which can be oxidized to produce ATP (de Oliveira et al., 2008) . The glycerol part of the triacylglycerol can be used to generate glucose by gluconeogenesis (Hazelwood and Lorenz, 1959) . This major metabolic pathway, called beta-oxidation, is active in the liver in order to maintain energy homeostasis (de Oliveira et al., 2008) .
In addition, Walter and Seebacher (2007) have indicated that gene expression of PGC-1α in the liver of avian embryos was higher at a relatively low incubation temperature of 35
• C during mid-incubation, which activates gluconeogenesis during embryonic development to produce glucose. Both reasons appear to be confirmed by the numerically higher relative liver weight found at an EST of 35.6
• C at E19 compared to all other EST treatments (Maatjens et al., 2016a) .
At IP, an EST of 35.6
• C resulted in a higher glycogen amount and concentration compared to all other EST, which was not accompanied by a higher plasma glucose level at IP. It might be possible that the longer time frame between E15 and IP up to 24 h at an EST of 35.6 compared to 38.9
• C (Maatjens et al., 2016a) provided time to build up glycogen stores from excessive glucose to an abundant level, which in addition could be used as energy for embryonic growth and development. This is supported by the lower relative yolk weight and expressed by the numerically higher YFBM at IP at an EST of 35.6
• C (Maatjens et al., 2016a ). An even lower residual yolk weight at EP compared to IP at an EST of 35.6
• C, in combination with the higher relative heart, spleen, stomach, and intestine weight (Maatjens et al., 2016a) , suggests that the higher uric acid level found at EP most probably originates from amino acid metabolism from the yolk and oral amnion consumption (Moran, 2007) . The higher residual yolk weight at an EST of 38.9
• C at IP and EP compared to 35.6 and 36.7
• C indicates lower yolk consumption and suggests that the higher uric acid levels found in studies at an EST of 38.9 compared to 37.8
• C possibly originate from a source other than yolk, such as, for example, from degradation of muscle protein as suggested by Molenaar et al. (2013) . It can be suggested that, depending on the EST the embryos experience, variation in uric acid level originates from different sources.
From EP until hatch, an EST of 35.6
• C resulted in a decreased hepatic glycogen amount due to glycolysis (Moran, 2007) , but at hatch, the hepatic glycogen amount remained higher compared to all other EST. For the embryo, hepatic gluconeogenesis is crucial, because glucose is the major source of energy during the time from IP until hatch, particularly during the energy demanding hatching process. Therefore, a higher hepatic glycogen amount might ease the hatching process and might contribute to improved chick quality at hatch. In combination with the higher YFBM found at an EST of 35.6 and 36.7
• C compared to an EST of 37.8 and 38.9
• C (Maatjens et al., 2016a) , this may suggest that nutrient efficiency is higher at an EST of 35.6 and 36.7
• C. Molenaar et al. (2010) indicated that protein efficiency was 3.2% higher at an EST of 37.8
• C compared to an EST of 38.9
• C, which supports our current findings. Therefore, it appears that a lower EST than 37.8
• C applied during the last wk of incubation might result in higher efficiencies for protein deposition.
In summary, an EST of 38.9
• C applied from E15 onward affected embryo metabolic rate and consequently chick embryo physiology. An EST of 35.6
• C applied from E15 onward influenced plasma glucose and uric acid concentration at E17. The large increase in hepatic glycogen amount and concentration from E19 to hatch suggests that an EST of 35.6
• C results in a lower metabolic rate and, consequently, it appears that the balance between metabolic rate and O 2 availability for the embryo is not disturbed during the last wk of incubation. Results of this study emphasize that an EST of 35.6 and 36.7
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